CYCLONE 2: A phase 3 study of abemaciclib with abiraterone in patients with metastatic castration-resistant prostate cancer

被引：0
|
作者：
Smith, Matthew Raymond
Piulats, Josep M.
Todenhofer, Tilman
Lee, Jae-Lyun
Arija, Jose Angel Arranz
Mazilu, Laura
Azad, Arun
Alonso-Gordoa, Teresa
McGovern, Ursula Brigid
Choudhury, Atish Dipankar
Ye, Dingwei
Suzuki, Hiroyoshi
Mckay, Rana R.
Ades, Steven
Flechon, Aude
Pieczonka, Christopher Michael
Hulstijn, Maarten
Lithio, Andrew
Nacerddine, Karim
Agarwal, Neeraj
机构：
[1] Massachusetts Gen Hosp, Canc Ctr, Boston, MA USA
[2] Inst Catal Oncol Bellvitge Inst Biomed Res, Barcelona, Spain
[3] Studienpraxis Urol, Nurtingen, Germany
[4] Univ Ulsan, Asan Med Ctr, Coll Med, Seoul, South Korea
[5] Hosp Univ Gregorio Maranon, Madrid, Spain
[6] Clin Emergency Hosp, Constanta, Romania
[7] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[8] Hosp Univ Ramon y Cajal, Med Oncol Dept, Madrid, Spain
[9] Univ Coll Hosp London, London, England
[10] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA
[11] Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China
[12] Toho Univ, Sakura Med Ctr, Chiba, Japan
[13] Univ Calif San Diego, La Jolla, CA USA
[14] Univ Vermont, Larner Coll Med, Burlington, VT USA
[15] Ctr Leon Berard, Lyon, France
[16] Associated Med Professionals NY, Syracuse, NY USA
[17] Eli Lilly & Co, Indianapolis, IN USA
[18] Huntsman Canc Inst, Salt Lake City, UT USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5001
引用
收藏
页数：1
相关论文
共 50 条
  • [1] CYCLONE 2: A phase 2/3, randomized, placebo-controlled study of abiraterone acetate plus prednisone with or without abemaciclib in patients with metastatic castration-resistant prostate cancer.
    Smith, Matthew Raymond
    Agarwal, Neeraj
    Todenhofer, Tilman
    Piulats, Josep M.
    Lee, Jae-Lyun
    Trepiakas, Redas
    Rao, Arpit
    Horvath, Lisa
    Lithio, Andrew
    Johnston, Erica L.
    Hulstijn, Maarten
    Nacerddine, Karim
    Sweeney, Christopher
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [2] CYCLONE 2: A phase II, randomized, placebo-controlled study of abiraterone acetate plus prednisone with or without abemaciclib in patients with metastatic castration-resistant prostate cancer.
    Smith, Matthew Raymond
    Agarwal, Neeraj
    Todenhoefer, Tilman
    Trepiakas, Redas
    Lee, Jae-Lyun
    Lithio, Andrew
    Chapman, Sonya
    Nacerddine, Karim
    Sweeney, Christopher
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [3] Abiraterone or Enzalutamide for Patients With Metastatic Castration-Resistant Prostate Cancer
    La, Jennifer
    Wang, Lin
    Corrigan, June K.
    Lang, Deborah
    Lee, Michelle H.
    Do, Nhan V.
    Brophy, Mary T.
    Paller, Channing J.
    Fillmore, Nathanael R.
    JAMA NETWORK OPEN, 2024, 7 (08)
  • [4] A phase 2 study of onvansertib in combination with abiraterone and prednisone in patients with metastatic castration-resistant prostate cancer (mCRPC).
    Einstein, David Johnson
    Choudhury, Atish Dipankar
    Saylor, Philip James
    Patterson, Jesse Christopher
    Croucher, Peter
    Ridinger, Maya
    Erlander, Mark G.
    Yaffe, Michael B.
    Bubley, Glenn
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [5] Abiraterone in the treatment of metastatic castration-resistant prostate cancer
    Mostaghel, Elahe A.
    CANCER MANAGEMENT AND RESEARCH, 2014, 6 : 39 - 51
  • [6] Abiraterone Acetate In Metastatic Castration-Resistant Prostate Cancer
    Yang, Lily P. H.
    DRUGS, 2011, 71 (15) : 2067 - 2077
  • [7] Abiraterone AcetateIn Metastatic Castration-Resistant Prostate Cancer
    Lily P. H. Yang
    Drugs, 2011, 71 : 2067 - 2077
  • [8] CYCLONE 1: abemaciclib in men with heavily pretreated metastatic castration-resistant prostate cancer (mCRPC)
    Agarwal, Neeraj
    Guana, Daniel Castellano
    Gordoa, Teresa A.
    Arija, Jose A.
    Colomba, Emeline
    Gravis, Gwenaelle
    Mourey, Loic
    Oudard, Stephanie
    Flechon, Aude
    Gonzalez, Macarena
    Maroto-Rey, Pablo
    Schweizer, Michael
    Gallardo, Enrique
    Nacerddine, Karim
    Appiach, Adams K.
    Balar, Arjun
    Johnston, Erica
    Piulats, Jose M.
    CANCER RESEARCH, 2023, 83 (08)
  • [9] PSA Flare With Abiraterone in Patients With Metastatic Castration-Resistant Prostate Cancer
    Burgio, Salvatore L.
    Conteduca, Vincenza
    Rudnas, Britt
    Carrozza, Francesco
    Campadelli, Enrico
    Bianchi, Emanuela
    Fabbri, Paolo
    Montanari, Marco
    Carretta, Elisa
    Menna, Cecilia
    De Giorgi, Ugo
    CLINICAL GENITOURINARY CANCER, 2015, 13 (01) : 39 - 43
  • [10] A Phase I Study of Capivasertib in Combination With Abiraterone Acetate in Patients With Metastatic Castration-Resistant Prostate Cancer
    Shore, Neal
    Mellado, Begona
    Shah, Satish
    Hauke, Ralph
    Costin, Dan
    Adra, Nabil
    Cullberg, Marie
    Teruel, Carlos Fernandez
    Morris, Thomas
    CLINICAL GENITOURINARY CANCER, 2023, 21 (02) : 278 - 285
12345